Hyperthyroidism

Endocrinology
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Novo Nordisk
Novo NordiskBAGSVAERD DENMARK, Denmark
1 program
Effects of Hyperthyroidism on Amount and Activity of Brown Adipose TissueN/A1 trial
Active Trials
NCT02133040Unknown10Est. May 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Novo NordiskEffects of Hyperthyroidism on Amount and Activity of Brown Adipose Tissue

Clinical Trials (1)

Total enrollment: 10 patients across 1 trials

NCT02133040Novo NordiskEffects of Hyperthyroidism on Amount and Activity of Brown Adipose Tissue

Effects of Hyperthyroidism on Amount and Activity of Brown Adipose Tissue

Start: May 2014Est. completion: May 202010 patients
N/AUnknown

Related Jobs in Endocrinology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space